Quantinno Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quantinno Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Buy	3,106 +110	+4%	+$14.9K	﹤0.01%	2999
2026 Q1	$383K	Buy	2,996 +1,057	+55%	+$132K	﹤0.01%	2896
2025 Q4	$236K	Sell	1,939 -355	-15%	-$40.7K	﹤0.01%	2974
2025 Q3	$230K	Buy	+2,294	New	+$207K	﹤0.01%	2664

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Quantinno Capital Management's XBI Position: Q2 2026 in Review

Quantinno Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.7% in Q2 2026, buying an estimated $14.9K and bringing the position to 3,106 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

Quantinno Capital Management first reported a position in XBI in Q3 2025 and has held it in 4 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Quantinno Capital Management held 3,106 shares of State Street SPDR S&P Biotech ETF worth $492K as of Q2 2026.
Quantinno Capital Management bought 110 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $14.9K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2999 holding.
Quantinno Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 4 quarters since.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.